Noile-Immune’s tech gets $315m vote of confidence to tackle solid tumors 10-Sep-2019 By Ben Hargreaves Noile-Immune signs its second high profile agreement, the latest with Adaptimmune to combine the companies’ technology in pre-clinical studies for the treatment of cancer.